Momelotinib-impurities | Pharmaffiliates

Momelotinib

Momelotinib, sold under the brand name Ojjaara, is an anticancer medication used for the treatment of myelofibrosis. Reference standards of Momelotinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Momelotinib - API Standards
    [catalogue_number] => PA 13 2970000
    [category_ids] => ,82,78,70,
    [chemical_name] => 
    [weight] => 414.47
    [form] => C23H22N6O2
    [cas] => 1056634-68-4
    [pslug] => 1056634-68-4-momelotinib-api-standards-pa132970000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 13 2970000

Momelotinib - API Standards


  • Catalogue No.:PA 13 2970000

  • CAS :

    1056634-68-4

  • Molecular Formula : C23H22N6O2

  • Molecular Weight : 414.47